RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer's disease from cognitively unimpaired amyloid-positive individuals

Sci Rep 14(1):10083 · 2024 · PMID 38698190

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

1,053편 검색→1,041편 판독→210편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Neuroanatomical MRI features distinguishing prodromal Alzheimer disease from cognitively unimpaired amyloid-positive individuals (prodromal[tiab] OR "mild cognitive impairment"[tiab] OR MCI[tiab] OR "early Alzheimer"[tiab] OR "prodromal Alzheimer"[tiab]) AND (amyloid[tiab] OR "amyloid-positive"[tiab] OR "amyloid positive"[tiab] OR "A-beta"[tiab] OR "Abeta"[tiab]) AND (MRI[tiab] OR "magnetic resonance imaging"[tiab] OR "structural MRI"[tiab] OR "brain volume"[tiab] OR "cortical thickness"[tiab] OR hippocampal[tiab]) AND ("cognitively unimpaired"[tiab] OR "cognitively normal"[tiab] OR "cognitively intact"[tiab] OR control[tiab] OR healthy[tiab])

출판 연도

2008: 1편120082009: 4편42010: 5편52011: 2편22012: 3편32013: 5편52014: 8편82015: 13편1320152016: 10편102017: 8편82018: 14편142019: 10편102020: 13편1320202021: 18편182022: 14편142023: 20편202024: 15편152025: 25편252026: 22편222026

선별된 210편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01pet · cortical48편

  1. 0.96

    Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer's disease from cognitively unimpaired amyloid-positive individuals 이 논문

    Kim HH, Kwon MJ, Jo S et al. · Scientific reports · 2024

  2. 0.82

    Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease

    Yoo HS, Kim HK, Lee JH et al. · Journal of Alzheimer's disease : JAD · 2024

  3. 0.79

    Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease

    Wolk DA, Das SR, Mueller SG et al. · Neurobiology of aging · 2017

  4. 0.78

    Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?

    Whitwell JL, Tosakulwong N, Weigand SD et al. · NeuroImage. Clinical · 2013

  5. 0.77

    Cerebellar subregional structural changes across the Alzheimer's disease continuum: a longitudinal analysis of cognitive and behavioural correlates

    Um YH, Wang SM, Kang DW et al. · Brain communications · 2026

  6. 0.77

    Selective disruption of the cerebral neocortex in Alzheimer's disease

    Desikan RS, Sabuncu MR, Schmansky NJ et al. · PloS one · 2010

  7. 0.77

    Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease

    Kljajevic V, Grothe MJ, Ewers M et al. · Neurobiology of aging · 2014

  8. 0.76

    Larger temporal volume in elderly with high versus low beta-amyloid deposition

    Chetelat G, Villemagne VL, Pike KE et al. · Brain : a journal of neurology · 2010

  9. 0.76

    Mapping 3-year changes in gray matter and metabolism in Abeta-positive nondemented subjects

    Araque Caballero MA, Brendel M, Delker A et al. · Neurobiology of aging · 2015

  10. 0.75

    In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging

    Zhao Y, Raichle ME, Wen J et al. · NeuroImage · 2017

  11. 0.74

    Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's disease

    Xia Y, Dean MW, Bourgeat P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  12. 0.71

    Executive function and cortical thickness in biomarker aMCI

    Scarisbrick DM, Keith CM, Vieira Ligo Teixeira C et al. · Applied neuropsychology. Adult · 2026

  13. 0.71

    Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

    Bourgeat P, Chetelat G, Villemagne VL et al. · Neurology · 2010

  14. 0.68

    Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity

    Mohanty R, Ferreira D, Nordberg A et al. · Alzheimer's research & therapy · 2023

  15. 0.68

    The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort

    Li C, Loewenstein DA, Duara R et al. · Journal of Alzheimer's disease : JAD · 2017

  16. 0.68

    The spatial distribution of coupling between tau and neurodegeneration in amyloid-beta positive mild cognitive impairment

    Robinson B, Bhamidi S, Dayan E · medRxiv : the preprint server for health sciences · 2023

  17. 0.68

    Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

    Jack CRJ, Lowe VJ, Weigand SD et al. · Brain : a journal of neurology · 2009

  18. 0.67

    Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical Stage

    Imabayashi E, Ishii K, Toyohara J et al. · Frontiers in aging neuroscience · 2022

  19. 0.67

    Basal forebrain atrophy correlates with amyloid beta burden in Alzheimer's disease

    Kerbler GM, Fripp J, Rowe CC et al. · NeuroImage. Clinical · 2015

  20. 0.66

    Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects

    Grothe MJ, Ewers M, Krause B et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  21. 0.64

    Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer's Disease

    Baek MS, Lee N, Kim JW et al. · Journal of clinical medicine · 2022

  22. 0.63

    Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved

    Hanseeuw B, Dricot L, Lhommel R et al. · Journal of Alzheimer's disease : JAD · 2016

  23. 0.62

    Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease

    Chetelat G, Villemagne VL, Pike KE et al. · Brain : a journal of neurology · 2011

  24. 0.62

    Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with beta-amyloidosis

    Knopman DS, Jack CRJ, Wiste HJ et al. · JAMA neurology · 2013

  25. 0.61

    Distinct brain volume changes associated with the head-turning sign and Neucop-Q response patterns in Alzheimer's disease

    Watanabe M, Bun S, Shimizu A et al. · Journal of Alzheimer's disease reports · 2026

  26. 0.61

    In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease

    Mak E, Bethlehem RAI, Romero-Garcia R et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2018

  27. 0.61

    Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging

    Ossenkoppele R, Smith R, Mattsson-Carlgren N et al. · JAMA neurology · 2021

  28. 0.61

    Explainable AI for MRI Alzheimer's disease classification: A comparative analysis

    Persson S, Svenberg H, Rial AM et al. · NeuroImage · 2026

  29. 0.59

    Distinct and joint effects of low and high levels of Abeta and tau deposition on cortical thickness

    Hani Hojjati S, Butler TA, Chiang GC et al. · NeuroImage. Clinical · 2023

  30. 0.59

    Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease

    Teipel S, Heinsen H, Amaro EJ et al. · Neurobiology of aging · 2014

  31. 0.58

    Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid beta at PET Imaging

    Rauchmann BS, Ghaseminejad F, Mekala S et al. · Radiology · 2020

  32. 0.58

    Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment

    Thurfjell L, Lotjonen J, Lundqvist R et al. · Neuro-degenerative diseases · 2012

  33. 0.58

    Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum

    Iaccarino L, La Joie R, Edwards L et al. · Cerebral cortex (New York, N.Y. : 1991) · 2021

  34. 0.56

    Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease

    Butler T, Harvey P, Deshpande A et al. · Neurobiology of aging · 2018

  35. 0.55

    Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment

    Leh SE, Kalin AM, Schroeder C et al. · Journal of Alzheimer's disease : JAD · 2016

  36. 0.54

    11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

    Jack CRJ, Lowe VJ, Senjem ML et al. · Brain : a journal of neurology · 2008

  37. 0.54

    Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration

    Thomas KR, Bangen KJ, Weigand AJ et al. · Neurology · 2020

  38. 0.54

    Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?

    Teipel S, Grothe MJ · European journal of nuclear medicine and molecular imaging · 2016

  39. 0.53

    Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

    Kotari V, Southekal S, Navitsky M et al. · Alzheimer's research & therapy · 2023

  40. 0.53

    Biological age acceleration in Alzheimer's disease modulates relative cortical to medial temporal lobe neurodegeneration

    Sreepada LP, Brown CA, Das SR et al. · Neurobiology of aging · 2025

  41. 0.53

    Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features

    Low A, Mak E, Malpetti M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2019

  42. 0.51

    Impact of Amyloid Pathology in Mild Cognitive Impairment Subjects: The Longitudinal Cognition and Surface Morphometry Data

    Chang HI, Hsu SW, Kao ZK et al. · International journal of molecular sciences · 2022

  43. 0.51

    T1 mapping in Alzheimer's disease: a quantitative MRI study with amyloid-PET correlation

    Gualco L, Montobbio N, Losa M et al. · European radiology experimental · 2026

  44. 0.51

    Relationship between atrophy and beta-amyloid deposition in Alzheimer disease

    Chetelat G, Villemagne VL, Bourgeat P et al. · Annals of neurology · 2010

  45. 0.51

    Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy

    Tateno A, Sakayori T, Kawashima Y et al. · International journal of geriatric psychiatry · 2015

  46. 0.50

    Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

    Stage ECJ, Svaldi D, Phillips M et al. · Alzheimer's research & therapy · 2020

  47. 0.50

    Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia

    Cai Y, Shi D, Lan G et al. · Neurology · 2024

  48. 0.50

    Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease

    Waragai M, Okamura N, Furukawa K et al. · Journal of the neurological sciences · 2009

02decline · hippocampal volume43편

  1. 0.88

    Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's disease

    Wearn A, Raket LL, Collins DL et al. · Brain communications · 2023

  2. 0.88

    Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study

    Chauveau L, Kuhn E, Palix C et al. · Frontiers in aging neuroscience · 2021

  3. 0.83

    Disease stage-specific atrophy markers in Alzheimer's disease

    Baumeister H, Gellersen HM, Polk SE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  4. 0.80

    Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of beta-amyloid deposition and neurodegeneration

    Busatto Filho G, Duran FLdS, Squarzoni P et al. · Journal of neuroscience research · 2021

  5. 0.78

    Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e

    Susanto TAK, Pua EPK, Zhou J · Journal of Alzheimer's disease : JAD · 2015

  6. 0.77

    Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease

    Xia Y, Dore V, Fripp J et al. · Neurology · 2024

  7. 0.77

    Stage-specific hippocampal network degeneration links amyloid-cognition relationships: Right subiculum as structural substrate for memory maintenance and biomarker in amyloid-positive mild cognitive impairment

    Wang Z, Huang L, Guan Y et al. · NeuroImage · 2026

  8. 0.75

    Hippocampal subregional texture features associated with Alzheimer's disease severity and cognition

    Uchida Y, Nishimaki K, Kan H et al. · Brain communications · 2026

  9. 0.73

    Multi-pathological contributions toward atrophy patterns in the Alzheimer's disease continuum

    Mohanty R, Ferreira D, Westman E · Frontiers in neuroscience · 2024

  10. 0.68

    Exploring the ATN classification system using brain morphology

    Heinzinger N, Maass A, Berron D et al. · Alzheimer's research & therapy · 2023

  11. 0.68

    White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

    Provenzano FA, Muraskin J, Tosto G et al. · JAMA neurology · 2013

  12. 0.67

    Hypothalamic atrophy and structural covariance in amnestic mild cognitive impairment and Alzheimer's dementia

    Pecher H, Storch M, Beyer F et al. · NeuroImage. Clinical · 2024

  13. 0.66

    Sex Moderates the Impact of Diagnosis and Amyloid PET Positivity on Hippocampal Subfield Volume

    Caldwell JZK, Berg JL, Shan G et al. · Journal of Alzheimer's disease : JAD · 2018

  14. 0.66

    Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis

    Andrews KA, Frost C, Modat M et al. · Neurobiology of aging · 2016

  15. 0.63

    Longitudinal trajectories of amyloid-beta-driven alterations in voxel-mirrored homotopic connectivity and cognitive decline in mild cognitive impairment

    Chi L, Qiao M, Huang A et al. · Journal of Alzheimer's disease : JAD · 2026

  16. 0.61

    Cerebral quantitative susceptibility mapping predicts amyloid-beta-related cognitive decline

    Ayton S, Fazlollahi A, Bourgeat P et al. · Brain : a journal of neurology · 2017

  17. 0.61

    Cognitively normal women with Alzheimer's disease proteinopathy show relative preservation of memory but not of hippocampal volume

    Caldwell JZK, Cummings JL, Banks SJ et al. · Alzheimer's research & therapy · 2019

  18. 0.61

    Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer's continuum

    Jiang J, Zhuo Z, Wang A et al. · Alzheimer's research & therapy · 2024

  19. 0.59

    Semantic intrusion errors as a function of age, amyloid, and volumetric loss: a confirmatory path analysis

    Zheng DD, Curiel Cid RE, Duara R et al. · International psychogeriatrics · 2022

  20. 0.57

    Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta

    Li Q, Pan FF, Huang Q et al. · Frontiers in aging neuroscience · 2022

  21. 0.57

    Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Abeta accumulation in cognitively normal older adults and adults with MCI

    Lim YY, Pietrzak RH, Bourgeat P et al. · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2015

  22. 0.57

    Amyloid pathology in the progression to mild cognitive impairment

    Insel PS, Hansson O, Mackin RS et al. · Neurobiology of aging · 2018

  23. 0.57

    Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype

    Laczo M, Svacova Z, Lerch O et al. · Journal of neurology · 2025

  24. 0.57

    Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

    Lopez OL, Klunk WE, Mathis C et al. · Neurology · 2014

  25. 0.56

    Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

    Petersen RC, Wiste HJ, Weigand SD et al. · JAMA neurology · 2016

  26. 0.56

    Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality

    Lopez OL, Becker JT, Chang Y et al. · Neurology · 2018

  27. 0.56

    Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline

    Wybitul M, Langer N, Hock C et al. · GeroScience · 2025

  28. 0.55

    Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer Disease

    Mori-Fegan DK, Wong YY, Noor S et al. · Alzheimer disease and associated disorders · 2026

  29. 0.54

    Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology

    Miotto EC, Brucki SMD, Cerqueira CT et al. · Journal of Alzheimer's disease : JAD · 2022

  30. 0.54

    Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

    Jessen F, Wolfsgruber S, Kleineindam L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  31. 0.54

    The role of glymphatic-related structural and functional imaging biomarkers in the pathological progression of Alzheimer's disease: a multimodal imaging-based study

    Tan M, Lan X, Anayiti X et al. · Quantitative imaging in medicine and surgery · 2026

  32. 0.53

    Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults

    Rodriguez-Vieitez E, Montal V, Sepulcre J et al. · Molecular psychiatry · 2021

  33. 0.52

    Brain amyloid, cortical thickness, and changes in activities of daily living

    Vassilaki M, Aakre JA, Kremers WK et al. · Annals of clinical and translational neurology · 2020

  34. 0.52

    Amyloid beta Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia

    Zhao Y, Tudorascu DL, Lopez OL et al. · JAMA neurology · 2018

  35. 0.52

    White Matter Abnormalities and Cognition in Aging and Alzheimer Disease

    Peter C, Sathe A, Shashikumar N et al. · JAMA neurology · 2025

  36. 0.52

    APOE epsilon4-associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

    Mares J, Kumar G, Sharma A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  37. 0.52

    Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

    Jack CRJ, Wiste HJ, Therneau TM et al. · JAMA · 2019

  38. 0.52

    A longitudinal investigation of locus coeruleus norepinephrine system integrity and cognitive performance across the Alzheimer's spectrum

    Sibahi A, Hosseini SA, Rahmouni N et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026

  39. 0.51

    Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

    Burnham SC, Bourgeat P, Dore V et al. · The Lancet. Neurology · 2016

  40. 0.51

    Brain structure and function as mediators of the effects of amyloid on memory

    Mattsson N, Insel PS, Aisen PS et al. · Neurology · 2015

  41. 0.50

    Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts

    Wang HF, Tan L, Hao XK et al. · Journal of Alzheimer's disease : JAD · 2015

  42. 0.50

    Influence of Comorbidity of Cerebrovascular Disease and Amyloid-beta on Alzheimer's Disease

    Yassi N, Hilal S, Xia Y et al. · Journal of Alzheimer's disease : JAD · 2020

  43. 0.50

    Relationship of sex differences in cortical thickness and memory among cognitively healthy subjects and individuals with mild cognitive impairment and Alzheimer disease

    Cieri F, Zhuang X, Cordes D et al. · Alzheimer's research & therapy · 2022

03diffusion · white matter34편

  1. 0.84

    Trajectory of stratum radiatum, lacunosum and moleculare integrity in Alzheimer's disease continuum

    Wang K, Shao B, Zeng Q et al. · Scientific reports · 2026

  2. 0.80

    In Vivo Detection of Changes Related to Cortical Columnar Organization and Neuroinflammation Across the AD Continuum

    Torso M, Ridgway GR, Hardingham I et al. · The journal of prevention of Alzheimer's disease · 2022

  3. 0.78

    Predicting risk of impending cognitive decline in asymptomatic individuals with early Alzheimer's disease: Insights from cortical diffusion MRI

    Overson DK, Truong TK, Petrella JR et al. · Imaging neuroscience (Cambridge, Mass.) · 2025

  4. 0.77

    Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-beta and Tau

    Tucholka A, Grau-Rivera O, Falcon C et al. · Journal of Alzheimer's disease : JAD · 2018

  5. 0.77

    Association of Superficial White Matter Microstructure With Cortical Pathology Deposition Across Early Stages of the AD Continuum

    Wang S, Zhang F, Zeng Q et al. · Neurology · 2025

  6. 0.75

    Magnetic resonance imaging indices for early Alzheimer's disease detection: Brain clearance markers

    Nakaya M, Kamagata K, Takabayashi K et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025

  7. 0.75

    Tracking a decade of structural changes in preclinical and prodromal Alzheimer's disease: insights from amyloid-beta pathology

    Qiu T, Liu ZQ, Gallego-Rudolf J et al. · medRxiv : the preprint server for health sciences · 2025

  8. 0.74

    Cortical Diffusivity, a Biomarker for Early Neuronal Damage, Is Associated with Amyloid-beta Deposition: A Pilot Study

    Debatisse J, Leng F, Ashraf A et al. · Cells · 2025

  9. 0.73

    Diffusion tensor image analysis along the perivascular space index alterations in Alzheimer's disease: associated with cerebrospinal fluid Abeta40 and cognition

    Han J, Xia Y, Jiao H et al. · Brain imaging and behavior · 2026

  10. 0.71

    Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction

    Zhang J, Yang X, Wang Y et al. · Radiology · 2025

  11. 0.68

    Diffusion kurtosis imaging detects cortical microstructural alterations in amyloid-positive MCI patients

    Nielsen RB, Parbo P, Ismail R et al. · Frontiers in dementia · 2025

  12. 0.67

    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease

    Spotorno N, Strandberg O, Vis G et al. · Brain : a journal of neurology · 2023

  13. 0.67

    White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration

    Kantarci K, Schwarz CG, Reid RI et al. · JAMA neurology · 2014

  14. 0.66

    Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation

    Lee P, Kim HR, Jeong Y · BMC neurology · 2020

  15. 0.65

    Projection to Latent Spaces Disentangles Pathological Effects on Brain Morphology in the Asymptomatic Phase of Alzheimer's Disease

    Casamitjana A, Petrone P, Molinuevo JL et al. · Frontiers in neurology · 2020

  16. 0.64

    NODDI-derived measures of microstructural integrity in medial temporal lobe white matter pathways are associated with Alzheimer's disease pathology and cognition

    Parker DM, Adams JN, Kim S et al. · Imaging neuroscience (Cambridge, Mass.) · 2025

  17. 0.63

    Cortical microstructural associations with CSF amyloid and pTau

    Nir TM, Villalon-Reina JE, Salminen L et al. · medRxiv : the preprint server for health sciences · 2023

  18. 0.61

    Periventricular and Perivascular-Space Diffusion MRI Measures, Amyloid Abnormality, and Executive Decline in the Alzheimer's Disease Continuum: A Longitudinal Study

    Chen C, Gu J, Hu Q et al. · Journal of magnetic resonance imaging : JMRI · 2026

  19. 0.60

    Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment

    Mito R, Raffelt D, Dhollander T et al. · Brain : a journal of neurology · 2018

  20. 0.60

    Diffusion Changes in Hippocampal Cingulum in Early Biologically Defined Alzheimer's Disease

    Chen Q, Abrigo J, Deng M et al. · Journal of Alzheimer's disease : JAD · 2023

  21. 0.58

    Cholinergic white matter pathways along the Alzheimer's disease continuum

    Nemy M, Dyrba M, Brosseron F et al. · Brain : a journal of neurology · 2023

  22. 0.57

    The Impact of Insulin Resistance on Grey Matter Changes Along the Alzheimer's Disease Continuum Insulin Resistance and Grey Matter in AD

    Bettonagli V, Galli A, Bazzoli E et al. · medRxiv : the preprint server for health sciences · 2025

  23. 0.57

    Fibre density and cross-section associate with hallmark pathology in early Alzheimer's disease

    Vanderlinden G, Radwan A, Christiaens D et al. · Alzheimer's research & therapy · 2025

  24. 0.57

    Fixel-Based Analysis Reveals Tau-Related White Matter Changes in Early Stages of Alzheimer's Disease

    Ahmadi K, Pereira JB, van Westen D et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024

  25. 0.56

    Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum

    Herdick M, Dyrba M, Fritz HCJ et al. · NeuroImage. Clinical · 2020

  26. 0.55

    Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition

    Raghavan S, Reid RI, Przybelski SA et al. · Brain communications · 2021

  27. 0.54

    An MRI-based macro- and microstructural neuroimaging-wide association study of subsequent cognitive impairment

    Duran T, Bilgel M, An Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  28. 0.51

    Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum

    Hall BJ, Aumont E, Hosseini SA et al. · Neurology · 2026

  29. 0.51

    Amyloid, Tau, and APOE in Alzheimer's Disease: Impact on White Matter Tracts

    Chandio BQ, Villalon-Reina JE, Nir TM et al. · bioRxiv : the preprint server for biology · 2024

  30. 0.50

    Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease

    Shahid SS, Wen Q, Risacher SL et al. · Brain : a journal of neurology · 2022

  31. 0.50

    Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease

    Reas ET, Hagler DJJ, White NS et al. · Alzheimer's research & therapy · 2017

  32. 0.50

    White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum

    Hirschfeld LR, Deardorff R, Chumin EJ et al. · Alzheimer's research & therapy · 2023

  33. 0.50

    Cortical microstructural changes along the Alzheimer's disease continuum

    Montal V, Vilaplana E, Alcolea D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018

  34. 0.50

    Association of deposition of tau and amyloid-beta proteins with structural connectivity changes in cognitively normal older adults and Alzheimer's disease spectrum patients

    Shigemoto Y, Sone D, Maikusa N et al. · Brain and behavior · 2018

04accuracy · learning28편

  1. 0.83

    MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease

    Liu W, Au LWC, Abrigo J et al. · Aging · 2021

  2. 0.71

    Hybrid-feature based spherical quasi-conformal registration for AD-induced hippocampal surface morphological changes

    Wang X, Cui W, Wu H et al. · Computer methods and programs in biomedicine · 2024

  3. 0.71

    Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia

    La Joie R, Perrotin A, de La Sayette V et al. · NeuroImage. Clinical · 2013

  4. 0.71

    Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories

    Li Y, Long G, Zhang X et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

  5. 0.69

    The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework

    Ricchi I, Griffa A, Corredor-Jerez R et al. · Journal of Alzheimer's disease : JAD · 2025

  6. 0.69

    Tracking early cognitive decline in preclinical AD with brain MRI similarity

    Sun J, Zufiria-Gerboles B, Passaretti M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  7. 0.67

    Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data

    Dyrba M, Barkhof F, Fellgiebel A et al. · Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2015

  8. 0.66

    Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers

    Dong A, Toledo JB, Honnorat N et al. · Brain : a journal of neurology · 2017

  9. 0.64

    Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning

    Hwang G, Abdulkadir A, Erus G et al. · Brain communications · 2022

  10. 0.63

    Diagnosing preclinical and clinical Alzheimer's disease with visual atrophy scales in the clinical practice

    Socher KLR, Nunes DM, Lopes DCP et al. · Arquivos de neuro-psiquiatria · 2025

  11. 0.63

    Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease

    Trzepacz PT, Hochstetler H, Yu P et al. · Dementia and geriatric cognitive disorders · 2016

  12. 0.61

    Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease

    Ofori E, DeKosky ST, Febo M et al. · NeuroImage. Clinical · 2019

  13. 0.59

    Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer's disease

    Xie L, Das SR, Wisse LEM et al. · Alzheimer's research & therapy · 2023

  14. 0.58

    Developing univariate neurodegeneration biomarkers with low-rank and sparse subspace decomposition

    Wang G, Dong Q, Wu J et al. · Medical image analysis · 2021

  15. 0.58

    Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns

    Lerch O, Ferreira D, Stomrud E et al. · Alzheimer's research & therapy · 2024

  16. 0.57

    Categorical predictive and disease progression modeling in the early stage of Alzheimer's disease

    Platero C · Journal of neuroscience methods · 2022

  17. 0.57

    Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI

    Petrone PM, Casamitjana A, Falcon C et al. · Alzheimer's research & therapy · 2019

  18. 0.55

    Leveraging Swin Transformer for Enhanced Diagnosis of Alzheimer's Disease Using Multi-Shell Diffusion MRI

    Dessain Q, Delinte N, Hanseeuw B et al. · IEEE transactions on bio-medical engineering · 2026

  19. 0.55

    Isometry Invariant Shape Descriptors for Abnormality Detection on Brain Surfaces Affected by Alzheimer's Disease

    Tu Y, Wen C, Zhang W et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2018

  20. 0.54

    Leveraging Swin Transformer for enhanced diagnosis of Alzheimer's disease using multi-shell diffusion MRI

    Dessain Q, Delinte N, Hanseeuw B et al. · ArXiv · 2025

  21. 0.53

    A Case-Control Clinical Trial on a Deep Learning-Based Classification System for Diagnosis of Amyloid-Positive Alzheimer's Disease RECODE

    Bae JB, Lee S, Oh H et al. · Psychiatry investigation · 2023

  22. 0.53

    MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

    Vemuri P, Wiste HJ, Weigand SD et al. · Neurology · 2009

  23. 0.52

    Predicting cognitive stage transition using p-tau181, Centiloid, and other measures

    Kwon HS, Kim JY, Koh SH et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  24. 0.51

    MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations

    Vemuri P, Wiste HJ, Weigand SD et al. · Neurology · 2009

  25. 0.51

    Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology

    Wu J, Dong Q, Zhang J et al. · Frontiers in neuroscience · 2021

  26. 0.51

    Combination of dynamic (11)C-PIB PET and structural MRI improves diagnosis of Alzheimer's disease

    Liu L, Fu L, Zhang X et al. · Psychiatry research · 2015

  27. 0.50

    Decoding the heterogeneity of Alzheimer's disease diagnosis and progression using multilayer networks

    Avelar-Pereira B, Belloy ME, O'Hara R et al. · Molecular psychiatry · 2023

  28. 0.50

    Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data

    Wittens MMJ, Sima DM, Brys A et al. · Alzheimer's research & therapy · 2025

05csf · cerebrospinal fluid27편

  1. 0.76

    Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume

    Carmichael O, Xie J, Fletcher E et al. · Neurobiology of aging · 2012

  2. 0.74

    Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease

    Batzu L, Westman E, Pereira JB · Neurobiology of aging · 2020

  3. 0.72

    Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum

    Allison SL, Koscik RL, Cary RP et al. · NeuroImage. Clinical · 2019

  4. 0.71

    PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts

    Haas AL, Olm P, Utz J et al. · Frontiers in aging neuroscience · 2023

  5. 0.68

    The role of clusterin in amyloid-beta-associated neurodegeneration

    Desikan RS, Thompson WK, Holland D et al. · JAMA neurology · 2014

  6. 0.67

    Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study

    Kaipainen A, Jaaskelainen O, Liu Y et al. · Journal of Alzheimer's disease : JAD · 2020

  7. 0.65

    Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease

    Alcolea D, Vilaplana E, Pegueroles J et al. · Neurobiology of aging · 2015

  8. 0.64

    A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non-converter Alzheimer's disease subjects with consideration for their amyloid beta status

    Morar U, Izquierdo W, Martin H et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

  9. 0.64

    Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Abeta Pathology in Non-demented Individuals

    Lindberg O, Martensson G, Stomrud E et al. · Frontiers in aging neuroscience · 2017

  10. 0.61

    Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study

    Wang YL, Chen J, Du ZL et al. · Frontiers in neurology · 2021

  11. 0.60

    The transitional association between beta-amyloid pathology and regional brain atrophy

    Insel PS, Mattsson N, Donohue MC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015

  12. 0.59

    Hippocampal subregions are differentially affected in the progression to Alzheimer's disease

    Greene SJ, Killiany RJ · Anatomical record (Hoboken, N.J. : 2007) · 2012

  13. 0.58

    Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer's disease

    Kang MS, Aliaga AA, Shin M et al. · Molecular psychiatry · 2021

  14. 0.58

    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

    Groot C, Smith R, Stomrud E et al. · Brain : a journal of neurology · 2023

  15. 0.56

    Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

    Liu Z, Shi D, Cai Y et al. · Alzheimer's research & therapy · 2024

  16. 0.56

    The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)

    Risacher SL, Kim S, Shen L et al. · Frontiers in aging neuroscience · 2013

  17. 0.55

    Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease

    Pettigrew C, Soldan A, Sloane K et al. · NeuroImage. Clinical · 2017

  18. 0.55

    Hippocampal Subfield Volume in Relation to Cerebrospinal Fluid Amyloid-ss in Early Alzheimer's Disease: Diagnostic Utility of 7T MRI

    Adeyemi OF, Gowland P, Bowtell R et al. · European journal of neurology · 2025

  19. 0.55

    Anterolateral entorhinal cortex thickness as a new biomarker for early detection of Alzheimer's disease

    Holbrook AJ, Tustison NJ, Marquez F et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  20. 0.53

    Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study

    Fleisher AS, Chen K, Quiroz YT et al. · JAMA neurology · 2015

  21. 0.52

    Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer's continuum

    Vilor-Tejedor N, Ciampa I, Operto G et al. · Alzheimer's research & therapy · 2021

  22. 0.52

    An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

    Brickman AM, Tosto G, Gutierrez J et al. · Neurology · 2018

  23. 0.52

    Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging

    Ottoy J, Niemantsverdriet E, Verhaeghe J et al. · NeuroImage. Clinical · 2019

  24. 0.51

    Biological mechanisms of resilience to tau pathology in Alzheimer's disease

    Svenningsson AL, Bocancea DI, Stomrud E et al. · Alzheimer's research & therapy · 2024

  25. 0.50

    Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's Disease signature regions and predicted future tau deposition

    Hu Q, Shi M, Li Y et al. · Research square · 2024

  26. 0.50

    Serial MRI and CSF biomarkers in normal aging, MCI, and AD

    Vemuri P, Wiste HJ, Weigand SD et al. · Neurology · 2010

  27. 0.50

    Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

    Fortea J, Vilaplana E, Carmona-Iragui M et al. · Lancet (London, England) · 2020

06functional · connectivity22편

  1. 0.80

    Multimodal Imaging of Tau Pathology and Network Connectivity Dynamics Across the Alzheimer's Continuum: A Pilot Study Using Second-Generation Tracer [(18)F]MK6240

    Piao S, Wang J, He K et al. · Academic radiology · 2026

  2. 0.79

    Identifying Brain Connectivity Using Network-Based Statistics in Amnestic Mild Cognitive Impairment Stratified by beta-Amyloid Positivity

    Kim JE, Kim SW, Choi M et al. · American journal of Alzheimer's disease and other dementias · 2019

  3. 0.76

    Multiplex Connectome Changes across the Alzheimer's Disease Spectrum Using Gray Matter and Amyloid Data

    Canal-Garcia A, Gomez-Ruiz E, Mijalkov M et al. · Cerebral cortex (New York, N.Y. : 1991) · 2022

  4. 0.67

    Tau-related grey matter network breakdown across the Alzheimer's disease continuum

    Pelkmans W, Ossenkoppele R, Dicks E et al. · Alzheimer's research & therapy · 2021

  5. 0.66

    Differences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairment

    Yi D, Choe YM, Byun MS et al. · Frontiers in aging neuroscience · 2015

  6. 0.65

    Degradation in intrinsic connectivity networks across the Alzheimer's disease spectrum

    Nuttall R, Pasquini L, Scherr M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2016

  7. 0.64

    Neuroplasticity and immune system are related to altered grey matter networks: a cohort study in sporadic Alzheimer's disease

    de Leeuw DM, Duits FH, Dicks E et al. · Brain communications · 2026

  8. 0.64

    Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden

    Drzezga A, Becker JA, Van Dijk KRA et al. · Brain : a journal of neurology · 2011

  9. 0.63

    Relationship between Amyloid-beta Deposition and the Coupling between Structural and Functional Brain Networks in Patients with Mild Cognitive Impairment and Alzheimer's Disease

    Zhang H, Hui ES, Cao P et al. · Brain sciences · 2021

  10. 0.62

    Distinct Spontaneous Brain Activity Patterns in Different Biologically-Defined Alzheimer's Disease Cognitive Stage: A Preliminary Study

    Zeng Q, Luo X, Li K et al. · Frontiers in aging neuroscience · 2019

  11. 0.62

    Alterations in topological and dynamical parameters correlate with disease biomarkers and neuropsychological scores in prodromic stages of dementia

    Monteverdi A, Cotta Ramusino M, Conca F et al. · Scientific reports · 2026

  12. 0.62

    Early stages of tau pathology and its associations with functional connectivity, atrophy and memory

    Berron D, Vogel JW, Insel PS et al. · Brain : a journal of neurology · 2021

  13. 0.62

    Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease

    Teipel SJ, Metzger CD, Brosseron F et al. · Journal of Alzheimer's disease : JAD · 2018

  14. 0.62

    Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia

    Chauveau L, Landeau B, Dautricourt S et al. · Brain : a journal of neurology · 2025

  15. 0.59

    Brain Structural Network Compensation Is Associated With Cognitive Impairment and Alzheimer's Disease Pathology

    Sheng X, Chen H, Shao P et al. · Frontiers in neuroscience · 2021

  16. 0.59

    Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks

    Grothe MJ, Teipel SJ · Human brain mapping · 2016

  17. 0.58

    Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease

    Ersoezlue E, Rauchmann BS, Schneider-Axmann T et al. · Neurobiology of aging · 2023

  18. 0.56

    Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease

    Franzmeier N, Duzel E, Jessen F et al. · Brain : a journal of neurology · 2018

  19. 0.55

    Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer's Disease

    Fischer FU, Wolf D, Tuscher O et al. · Frontiers in aging neuroscience · 2021

  20. 0.54

    Alzheimer's pathology targets distinct memory networks in the ageing brain

    Maass A, Berron D, Harrison TM et al. · Brain : a journal of neurology · 2019

  21. 0.53

    Functional redundancy of the posterior hippocampi is selectively disrupted in non-demented older adults with beta-amyloid deposition

    Blujus JK, Cole MW, Festa EK et al. · Neuroimage. Reports · 2025

  22. 0.50

    EEG-fMRI Signal Coupling Is Modulated in Subjects With Mild Cognitive Impairment and Amyloid Deposition

    Michels L, Riese F, Meyer R et al. · Frontiers in aging neuroscience · 2021

07blood flow · cerebral7편

  1. 0.75

    Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease

    Nielsen RB, Parbo P, Ismail R et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  2. 0.70

    Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease

    Madsen LS, Parbo P, Ismail R et al. · Neurobiology of aging · 2023

  3. 0.66

    Association of brain amyloid-beta with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

    Mattsson N, Tosun D, Insel PS et al. · Brain : a journal of neurology · 2014

  4. 0.61

    Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-beta-Positive Subjects in the Alzheimer's Disease Continuum

    Tosun D, Schuff N, Jagust W et al. · Neuro-degenerative diseases · 2016

  5. 0.58

    Capillary dysfunction in healthy elderly APOE epsilon4 carriers with raised brain Abeta deposition

    Madsen LS, Kjeldsen PL, Ismail R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  6. 0.57

    Cerebral perfusion correlates with amyloid deposition in patients with mild cognitive impairment due to Alzheimer's disease

    Wang C, Ji D, Su X et al. · The journal of prevention of Alzheimer's disease · 2025

  7. 0.52

    Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease

    McDade E, Kim A, James J et al. · Neurology · 2014

08mice · hippocampal1편

  1. 0.70

    Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease

    Kothapalli SVVN, Benzinger TL, Aschenbrenner AJ et al. · Journal of Alzheimer's disease : JAD · 2022